Thats not a risk-reward calculation Id sign off on, and I dont think you should either, at least not without doing something about the unregulated half of the equation
With proper aseptic training and follow-up, select patients may self-inject subcutaneously, enhancing adherence and convenience
Dosage-unit testing Finally, For capsules or tablets, evaluate content uniformity, assay, weight variation, disintegration, and other suitable finished-product tests
The patient may show symptoms of hypovolemia, such as low blood pressure, rapid heart rate, or dizziness
Reconstitution A: 5 mg vial + 2 mL BAC water (2.5 mg/mL) practical mid-range dilution where 1 mg = 40 units
Products may carry risks, including immunogenicity or impurities